Maprotiline

DEA Class;  Rx

Common Brand Names; Ludiomil

  • Antidepressants, TCAs

Tetracyclic antidepressant of dibenzo-bicyclo-octadiene derivation; efficacy is similar to the TCAs for depression; occasionally administered for other indications.

Indicated for the treatment of major depression.

Hypersensitivity

Severe cardiovascular disorders

Narrow angle glaucoma

Within 14 days of MAO inhibitors may cause serotonin syndrome

Any drugs or conditions that prolong QT interval

Acute recovery post-MI

Common

  • Fatigue

  • Sedation

  • Lethargy

  • Weakness

  • Constipation

  • Dry mouth

  • Blurred vision

Less Common

  • Agitation

  • Anxiety

  • Headache

  • Insomnia

  • Nausea

  • Vomiting

  • Sweating

Infrequent

  • Orthostatic hypotension, ECG changes, tachycardia

  • Confusion, EPS, dizziness, paresthesia, tinnitus

  • Rash

  • Incr LFTs

  • Sexual dysfunction

Rare

  • Seizure

  • Agranulocytosis

  • Thrombocytopenia

  • Eosinophilia

  • Leukopenia

  • SIADH

Caution in BPH, urinary/GI retention, increased IOP, hyperthyroidism, open-angle glaucoma, seizure disorder, brain tumor, respiratory impairment

Clinical worsening & suicide ideation may occur despite medication in adolescents & young adults (18-24 years)

Risk of anticholinergic side-effects

May cause sedation (may impair physical and mental abilities), orthostatic hypotension, and anticholinergic effects

Pregnancy Category: B

Lactation: avoid during breastfeeding

Adults

225 mg/day PO.

Geriatric

225 mg/day PO.

Adolescents

Safety and efficacy have not been established.

Children

Safety and efficacy have not been established.

Maprotiline hydrochloride

tablet

  • 25mg
  • 50mg
  • 75mg

About the Author

You may also like these

0